Standout Papers
Immediate Impact
89 standout
Citing Papers
Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes
2025 Standout
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity
2025 Standout
Works of Jaime P. Almandoz being referenced
What is clinically relevant weight loss for your patients and how can it be achieved? A narrative review
2022
Switching Between Glucagon-Like Peptide-1 Receptor Agonists: Rationale and Practical Guidance
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Jaime P. Almandoz | 261 | 90 | 342 | 482 | 361 | 57 | 1.4k | |
| Josephine M. Norquist | 399 | 45 | 174 | 637 | 220 | 70 | 2.1k | |
| Marlene Chakhtoura | 349 | 31 | 342 | 583 | 183 | 43 | 1.4k | |
| Tormod Brenn | 129 | 14 | 165 | 357 | 343 | 55 | 1.8k | |
| R D Cohen | 171 | 21 | 304 | 391 | 179 | 56 | 2.1k | |
| Estella Musacchio | 225 | 18 | 563 | 262 | 117 | 56 | 1.9k | |
| José Antonio Balsa | 359 | 26 | 377 | 215 | 284 | 55 | 1.2k | |
| Ambika P. Ashraf | 306 | 31 | 372 | 546 | 446 | 91 | 1.6k | |
| Celia Rodd | 269 | 40 | 205 | 446 | 443 | 91 | 2.1k | |
| Elizabeth M Haney | 274 | 16 | 131 | 555 | 546 | 36 | 2.0k | |
| Ramin Alemzadeh | 593 | 27 | 384 | 384 | 962 | 80 | 2.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...